Table 1 Patient characteristics and... | American Society of Hematology

Table 1

Patient characteristics and biochemical profiles

	Control subjects, n = 35	Stroke patients, n = 25	P*
Men:women	19:16	21:04	—
Age, y	49.5 ± 16.9	56.0 ± 12.5	—
T-CHOL, mg/dL	150.8 ± 32.9	151.4 ± 34.3	.28
TG, mg/dL	109 ± 38.5	123.8 ± 72.5	.46
LDL-C/HDL-C	2.2 ± 0.9	2.8 ± 1.2	.06
HDL-C, mg/dL	41.8 ± 12.1	32.7 ± 6.6	.16
LDL-C, mg/dL	92.6 ± 33.5	105.4 ± 34.5	.20
L5/LDL%	0.5 ± 0.3	19.1 ± 10.6	<.001
[L5], mg/dL†	0.5 ± 0.4	20.6 ± 13.5	<.001

	Control subjects, n = 35	Stroke patients, n = 25	P*
Men:women	19:16	21:04	—
Age, y	49.5 ± 16.9	56.0 ± 12.5	—
T-CHOL, mg/dL	150.8 ± 32.9	151.4 ± 34.3	.28
TG, mg/dL	109 ± 38.5	123.8 ± 72.5	.46
LDL-C/HDL-C	2.2 ± 0.9	2.8 ± 1.2	.06
HDL-C, mg/dL	41.8 ± 12.1	32.7 ± 6.6	.16
LDL-C, mg/dL	92.6 ± 33.5	105.4 ± 34.5	.20
L5/LDL%	0.5 ± 0.3	19.1 ± 10.6	<.001
[L5], mg/dL†	0.5 ± 0.4	20.6 ± 13.5	<.001

Data are expressed as the mean ± SD.

[L5], concentration of L5; L5/LDL%, L5 percentage in LDL; T-CHOL, total cholesterol; TG, triglyceride.

P value determined by using the Wilcoxon signed-rank test.

L5/LDL % × LDL-C (in milligrams per deciliter).